SCM
AZN icon

Sterling Capital Management’s AstraZeneca AZN Stock Holding History

Sterling Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
14,562
+1,185
+9% +$223K 0.05% 300
2026
Q1 		$2.64M Buy
13,377
+5,832
+77% +$1.12M 0.05% 275
2025
Q4 		$1.39M Buy
7,545
+372
+5% +$65.2K 0.02% 535
2025
Q3 		$1.1M Sell
7,173
-1,910
-21% -$289K 0.02% 600
2025
Q2 		$1.27M Sell
9,083
-66
-0.7% -$9.25K 0.02% 545
2025
Q1 		$1.34M Buy
9,149
+917
+11% +$133K 0.02% 500
2024
Q4 		$1.08M Buy
8,232
+2,917
+55% +$408K 0.01% 614
2024
Q3 		$828K Buy
+5,315
New +$858K 0.01% 650
2019
Q3 		$249K Sell
2,795
-867
-24% -$75.2K ﹤0.01% 809
2019
Q2 		$302K Buy
3,662
+493
+16% +$38.7K ﹤0.01% 798
2019
Q1 		$256K Buy
3,169
+264
+9% +$20.8K ﹤0.01% 794
2018
Q4 		$221K Sell
2,905
-1,113
-28% -$86.9K ﹤0.01% 813
2018
Q3 		$318K Sell
4,018
-64
-2% -$4.84K ﹤0.01% 816
2018
Q2 		$287K Buy
4,082
+247
+6% +$17.8K ﹤0.01% 799
2018
Q1 		$268K Buy
3,835
+125
+3% +$8.66K ﹤0.01% 810
2017
Q4 		$257K Buy
3,710
+52
+1% +$3.51K ﹤0.01% 826
2017
Q3 		$248K Buy
+3,658
New +$231K ﹤0.01% 852
2017
Q2 		– Sell
-4,927
Closed -$307K – 934
2017
Q1 		$307K Buy
4,927
+281
+6% +$16.4K ﹤0.01% 847
2016
Q4 		$254K Buy
+4,646
New +$264K ﹤0.01% 868
2016
Q3 		– Sell
-4,350
Closed -$263K – 906
2016
Q2 		$263K Sell
4,350
-3,117
-42% -$181K ﹤0.01% 842
2016
Q1 		$421K Buy
+7,467
New +$449K ﹤0.01% 774

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sterling Capital Management's AZN Position: Q2 2026 in Review

Sterling Capital Management increased its AstraZeneca (AZN) stake by 8.9% in Q2 2026, buying an estimated $223K and bringing the position to 14,562 shares worth $2.76M. The position accounts for 0.05% of the portfolio, ranked #300.

Sterling Capital Management first reported a position in AZN in Q1 2016 and has held it in 21 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sterling Capital Management held 14,562 shares of AstraZeneca worth $2.76M as of Q2 2026.
  • Sterling Capital Management bought 1,185 AstraZeneca shares in Q2 2026, an estimated $223K.
  • AstraZeneca made up 0.05% of Sterling Capital Management's portfolio in Q2 2026, its #300 holding.
  • Sterling Capital Management first reported a position in AstraZeneca in Q1 2016 and has held it in 21 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.